Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Sequenom Inc (SQNM) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 286,180
  • Shares Outstanding, K 119,220
  • Annual Sales, $ 128,280 K
  • Annual Income, $ -16,330 K
  • 36-Month Beta 1.17
  • Price/Sales 2.23
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.33
  • Most Recent Earnings -0.11 on 05/04/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.34 +2.14%
on 08/22/16
2.40 -0.42%
on 09/06/16
+0.02 (+0.84%)
since 08/05/16
3-Month
0.82 +191.46%
on 07/19/16
2.40 -0.42%
on 09/06/16
+1.29 (+117.27%)
since 06/06/16
52-Week
0.82 +191.46%
on 07/19/16
2.53 -5.53%
on 09/18/15
+0.42 (+21.32%)
since 09/04/15

Most Recent Stories

More News
LabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

Sequenom, Inc. ("Sequenom"), a wholly-owned subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), announced the final results, as of 5:00 p.m., New York City...

LabCorp Subsidiary Sequenom, Inc. Announces Early Tender Results for Tender Offers and Successful Completion of Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

Sequenom, Inc. ("Sequenom"), a wholly-owned subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), announced the results, as of 5:00 p.m., New York City time,...

LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

Sequenom, Inc., a wholly-owned subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), announced the commencement of cash tender offers (the "Tender Offers")...

How These Biotech Stocks are Faring? -- Immunomedics, Sequenom, INSYS Therapeutics, and Regulus Therapeutics

Biotechnology is well known for cycling between booms and busts, making it both an interesting and intimidating space to navigate. It is a place where investors either come out soaring to the top or the...

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Sequenom, Inc.

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of California, case no. 3:16-cv-02084, on behalf of shareholders...

Laboratory Corporation of America(R) Holdings Successfully Completes Acquisition of Sequenom, Inc.

Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the successful completion of the offering period for the cash tender offer by its direct wholly owned...

LabCorp's Takeover of Sequenom Wins Antitrust Clearance

LabCorp (LH) recently got the antitrust review clearance for its previously announced acquisition of Sequenom.

LabCorp's Acquisition of Sequenom Clears Antitrust Review

Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, ...

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sequenom, Inc. (SQNM)

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Sequenom, Inc. ("Sequenom" or the "Company") (Nasdaq:SQNM) in the United States District Court for the Southern District...

LabCorp Commences Cash Tender Offer for All Outstanding Shares of Sequenom, Inc.

Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Sequenom, Inc. (NASDAQ:...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations...

See More

Support & Resistance

2nd Resistance Point 2.40
1st Resistance Point 2.40
Last Price 2.39
1st Support Level 2.39
2nd Support Level 2.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.